{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:05:23Z","timestamp":1792677923468,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neulet.2024.137833","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T17:15:14Z","timestamp":1716484514000},"page":"137833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Clinical values of serum C5a in Alzheimer\u2019s disease patients with different dementia stages"],"prefix":"10.1016","volume":"836","author":[{"given":"Caijia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2024.137833_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neulet.2024.137833_b0010","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer's disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2024.137833_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-019-0524-y","article-title":"Alzheimer's disease: risk factors and potentially protective measures","volume":"26","author":"Silva","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neulet.2024.137833_b0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer's disease","volume":"57","author":"A.a. r,","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neulet.2024.137833_b0025","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine Study, Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2024.137833_b0030","first-page":"192","article-title":"Treatment Effects of Vortioxetine on Cognitive Functions in Mild Alzheimer's Disease Patients with Depressive Symptoms: A 12 Month","volume":"6","author":"Cumbo","year":"2019","journal-title":"Open-Label, Observational Study, J Prev Alzheimers Dis."},{"key":"10.1016\/j.neulet.2024.137833_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-022-02584-x","article-title":"Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases","volume":"19","author":"Boyd","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2024.137833_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","article-title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease","volume":"72","author":"Ozben","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.neulet.2024.137833_b0045","first-page":"2701748","article-title":"Analysis of Correlation between Serum Inflammatory Factors and Cognitive Function","volume":"2022","author":"Lu","year":"2022","journal-title":"Language, and Memory in Alzheimer's Disease and Its Clinical Significance, Comput Math Methods Med."},{"key":"10.1016\/j.neulet.2024.137833_b0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the Complement System in the Clinical Immunology Laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.neulet.2024.137833_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnins.2020.00023","article-title":"Complement System in Brain Architecture and Neurodevelopmental Disorders","volume":"14","author":"Magdalon","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neulet.2024.137833_b0060","article-title":"The Complement System in the Central Nervous System: From Neurodevelopment to Neurodegeneration","volume":"12","author":"Chen","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neulet.2024.137833_b0065","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.tibs.2020.04.004","article-title":"Emerging Insights into the Structure and Function of Complement C5a Receptors","volume":"45","author":"Pandey","year":"2020","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.neulet.2024.137833_b0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","article-title":"Modulation of C5a\u2013C5aR1 signaling alters the dynamics of AD progression","volume":"19","author":"Carvalho","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2024.137833_b0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-015-0369-6","article-title":"Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease","volume":"12","author":"Landlinger","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2024.137833_b0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neulet.2024.137833_b0085","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1096\/fj.11-202382","article-title":"Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis","volume":"26","author":"Pavlovski","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.neulet.2024.137833_b0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/imm.12489","article-title":"C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus","volume":"146","author":"Mahajan","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.neulet.2024.137833_b0095","doi-asserted-by":"crossref","unstructured":"G.H. Kim, J. Mocco, D.K. Hahn, C.P. Kellner, R.J. Komotar, A.F. Ducruet, W.J. Mack, E.S. Connolly, Jr., Protective effect of C5a receptor inhibition after murine reperfused stroke, Neurosurgery. 63 (2008) 122-125; discussion 125-126, http:\/\/dx.doi.org\/10.1227\/01.NEU.0000335079.70222.8D.","DOI":"10.1227\/01.NEU.0000313581.36723.8D"},{"key":"10.1016\/j.neulet.2024.137833_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-10-25","article-title":"Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology","volume":"10","author":"Fonseca","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2024.137833_b0105","doi-asserted-by":"crossref","DOI":"10.1177\/1759091416687871","article-title":"C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta","volume":"9","author":"Hernandez","year":"2017","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neulet.2024.137833_b0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-Mediated Events in Alzheimer's Disease: Mechanisms and Potential Therapeutic Targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2024.137833_b0115","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann Transl Med."},{"key":"10.1016\/j.neulet.2024.137833_b0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbi.2019.08.004","article-title":"Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation","volume":"82","author":"Wadhwa","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neulet.2024.137833_b0125","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","article-title":"The complement cascade in Alzheimer's disease: a systematic review and meta-analysis","volume":"26","author":"Krance","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2024.137833_b0130","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/alz.12799","article-title":"Complement dysregulation and Alzheimer's disease in Down syndrome","volume":"19","author":"Veteleanu","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neulet.2024.137833_b0135","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.neulet.2024.137833_b0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12883-023-03256-w","article-title":"Correlation of serum complement factor 5a level with inflammatory response and cognitive function in patients with Alzheimer's disease of different severity","volume":"23","author":"Li","year":"2023","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neulet.2024.137833_b0145","first-page":"1","article-title":"Influence of education level on MMSE and MoCA scores of elderly inpatients","author":"Wu","year":"2021","journal-title":"Appl. Neuropsychol. Adult"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024002118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394024002118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T13:09:47Z","timestamp":1734613787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394024002118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"alternative-id":["S0304394024002118"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137833","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical values of serum C5a in Alzheimer\u2019s disease patients with different dementia stages","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2024.137833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"137833"}}